Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]
Phase 3 trial evaluating efficacy and safety of octreotide subcutaneous depot in patients with acromegaly has completed with posted results.
-
EMA approval · 2026-08-05EMA Authorised: Signifor (pasireotide) — Recordati Rare Diseases
Signifor (pasireotide) has been authorised in the EU for acromegaly and pituitary ACTH hypersecretion.
-
EMA approval · 2026-08-03EMA Authorised: Palsonify (paltusotine hydrochloride) — Crinetics Pharmaceuticals Europe GmbH
Palsonify (paltusotine hydrochloride) has been authorised in Europe for acromegaly by Crinetics Pharmaceuticals Europe GmbH.
-
EMA approval · 2026-06-15EMA Authorised: Palsonify (paltusotine hydrochloride) — Crinetics Pharmaceuticals Europe GmbH
Palsonify (paltusotine hydrochloride) has been authorised in Europe for acromegaly, with Crinetics Pharmaceuticals Europe GmbH as the MAH an…
-
EMA approval · 2026-06-10EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB
Oczyesa (octreotide hydrochloride) has been authorised for use in the European Union, with Camurus AB as the marketing authorization holder,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) [Phase 2]
This document describes an ongoing Phase 2 clinical trial (ACROBAT Advance) evaluating the long-term safety and efficacy of paltusotine for …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly [Phase 2]
A Phase 2 clinical trial is evaluating ALXN2420 vs placebo in combination with somatostatin analogs for acromegaly; the study is currently r…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
This clinical trial update notes that the NICHD study on pituitary tumors and related hypothalamic disorders is actively recruiting, coverin…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs [Phase 3]
A Phase 3 clinical trial is assessing the efficacy and safety of Debio 4126 in adults with acromegaly who were previously treated with somat…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
This entry reports the completion of a clinical trial studying peri-operative dynamics of the growth hormone axis in subjects with acromegal…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) [Phase 3]
PATHFNDR-2 is a Phase 3 study assessing the safety and efficacy of Paltusotine for acromegaly. Results were posted on January 13, 2026.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly [Phase 3]
This document covers a Phase 3 trial evaluating the safety and efficacy of paltusotine for acromegaly. Results were posted on 2026-01-13.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study of MAR002 in Healthy Men [Phase 1]
A Phase 1 clinical trial of MAR002 in healthy men is under recruitment for Acromegaly, sponsored by Marea Therapeutics.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Ultrasound in Predicting Difficult Intubation in Acromegaly Patients
A planned clinical trial will evaluate whether airway ultrasonography can predict difficult intubation in patients with acromegaly due to pi…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly [Phase 3]
This Phase 3 trial evaluated the long-term safety of Octreotide Subcutaneous Depot in patients with acromegaly. The study sponsored by Camur…
-
EMA approval · 2025-12-03EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB
The EMA authorised Oczyesa (octreotide hydrochloride) from Camurus AB for the treatment of acromegaly.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Reproducibility and Utility of OGTT in Acromegaly [NA]
A completed clinical trial evaluating the reproducibility and utility of the oral glucose tolerance test in acromegaly.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) [Phase 1]
Phase 1 study evaluating Debio 4126 in participants with acromegaly or functioning gastroenteropancreatic neuroendocrine tumors has been ter…
-
FDA approval · 2025-09-25FDA Approved: PALSONIFY — Original Application (Crinetics Pharmaceuticals, Inc.)
The FDA approved Palsonify (paltusotine) from Crinetics Pharmaceuticals as an original drug approval for the treatment of acromegaly. This m…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Effects of Pasireotide Lar Therapy on Bone Metabolism
A clinical trial is investigating the effects of pasireotide long-acting release on bone metabolism in individuals with acromegaly caused by…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly [NA]
A completed clinical trial comparing ketogenic and Mediterranean diets in active acromegaly, evaluating metabolic and hormonal parameters.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Prospective Study of Outcome After Therapy for Acromegaly
A prospective study evaluating outcomes after therapy for acromegaly has completed.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study
A clinical trial led by Istituto Auxologo Italiano evaluating therapies for acromegaly with a focus on acral morpho-functional outcomes; cur…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Korean Regulatory Post Marketing Surveillance for Somavert
A Korean regulatory post-marketing surveillance study of Somavert (pegvisomant) in acromegaly is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Phase 1 Study of TE-8214 Solution in Healthy Volunteers [Phase 1]
A Phase 1 trial of TE-8214 Solution in healthy volunteers has completed. Acromegaly is listed as the condition of interest for the study.